Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice

2008196 citationsJournal Article

Authors

Good health and well-being

Published in: Experimental Neurology

Volume 213, Issue 2, pp. 448-455

Field-Weighted Citation Impact: 3.63